ADIPOQ and obesity due to melanocortin 4 receptor deficiency: More research is needed to elucidate the mechanisms and potential pathways for increasing adiponectin in different populations and more importantly its potential benefit in the treatment and prevention of obesity associated metabolic diseases such as type 2 diabetes .